Ultra-hydrophilic stent platforms promote early vascular healing and minimise late tissue response: a potential alternative to second-generation drug-eluting stents
EuroIntervention 2017;12:2148-2156 published online December 2016. DOI: 10.4244/EIJ-D-15-00497
Kumaran Kolandaivelu1,2*, MD, PhD; Lynn Bailey3, AS, LATg; Stefano Buzzi4, PhD; Arik Zucker4, MSc; Vincent Milleret5, PhD; Algirdas Ziogas5,6, PhD; Martin Ehrbar5, PhD; Ahmed A. Khattab7, MD, PhD; James R.L. Stanley3, DVM, MS; Gee K. Wong3, BS, HTL; Brett Zani3, PhD; Peter M. Markham3, MS; Abraham R. Tzafriri3, PhD; Deepak L. Bhatt2, MD, MPH; Elazer R. Edelman1,2, MD, PhD
1. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA; 2. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; 3. CBSET, Lexington, MA, USA; 4. Qvanteq AG, Zu
Aims: Simple surface modifications can enhance coronary stent performance. Ultra-hydrophilic surface (UHS) treatment of contemporary bare metal stents (BMS) was assessed